-
Signature
-
/s/ Raphael Deferiere, attorney-in-fact
-
Issuer symbol
-
CNTA
-
Transactions as of
-
17 Nov 2025
-
Net transactions value
-
-$743,200
-
Form type
-
4
-
Filing time
-
18 Nov 2025, 16:17:11 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Bush Tia L |
Chief Technology & Quality Ofc |
C/O CENTESSA PHARMACEUTICALS PLC, 3RD FL., 1 ASHLEY RD, ALTRINCHAM, CHESHIRE, UNITED KINGDOM |
/s/ Raphael Deferiere, attorney-in-fact |
18 Nov 2025 |
0001863418 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CNTA |
Ordinary Shares |
Options Exercise |
$376,800 |
+40,000 |
+33% |
$9.42 |
161,503 |
17 Nov 2025 |
Direct |
F1 |
| transaction |
CNTA |
Ordinary Shares |
Sale |
$1,120,000 |
-40,000 |
-25% |
$28.00 |
121,503 |
17 Nov 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CNTA |
Share Option (right to buy) |
Options Exercise |
$0 |
-40,000 |
-10% |
$0.000000 |
360,338 |
17 Nov 2025 |
Ordinary Shares |
40,000 |
$9.42 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: